Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $625
Portfolio Pulse from jenniferd'souza@benzinga.com
Barclays analyst Luke Sergott maintains an Overweight rating on Thermo Fisher Scientific (NYSE:TMO) and raises the price target from $590 to $625.
July 27, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Overweight rating on Thermo Fisher Scientific and raises the price target from $590 to $625, indicating a positive outlook for the company.
The raised price target by Barclays indicates their belief in the company's potential for growth. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100